Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.50
Delayed Data
As of May 02
 +0.12 / +8.70%
Today’s Change
0.75
Today|||52-Week Range
2.50
+12.78%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.38
Today’s open1.39
Day’s range1.35 - 1.50
Volume895,135
Average volume (3 months)482,621
Market cap$214.7M
Dividend yield--
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...+0.14+2.33%
AMPEAmpio Pharmaceutical...-0.04-0.95%
MNOVMediciNova Inc+0.12+1.74%
TTPHTetraphase Pharmaceu...-0.05-0.89%
Data as of 05/02/2016

Financials

Last reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
Chief Operating Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts

Partner Offers

Search for Jobs